6:59 PM ET
Earnings Call
▶ Call
Mesa Laboratories Earnings Call: Key Takeaways
Mesa Labs is restructuring Clinical Genomics to prioritize profitability over scale while providing its first-ever full-year guidance and initiating a $40 million share repurchase program.